Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) Annual Meeting brings together researchers, clinicians, and industry leaders focused on advancing cancer immunotherapy through innovative science and translational insight. As immuno‑oncology research increasingly relies on complex, physiologically relevant models, teams face growing challenges around variability, scalability, and data confidence.
Visit Molecular Devices at Booth 423 to explore integrated, workflow‑focused solutions designed to support immunotherapy research across advanced cellular and 3D models—helping teams generate reproducible, decision‑ready data faster.
At the booth, you’ll see how to:
- Standardize and scale complex immuno‑oncology assays by reducing manual variability across 2D and 3D workflows.
- Automate cell culture for immune cell and tumor model workflows by leveraging AI-driven decision-making to maintain consistent, healthy cultures while reducing hands-on burden.
- Build confidence in phenotypic and functional readouts from immune‑oncology models using high‑quality imaging and flexible quantitative measurement.
- Accelerate insight from complex biological systems through AI‑assisted image analysis that simplifies interpretation without added informatics burden.
- Support adoption of organoid and 3D models with solutions designed to improve consistency from culture through downstream analysis.
- Connect culture, measurement, imaging, and analysis into a cohesive workflow that supports both exploratory research and scalable screening.
Click below to schedule some time with our experts at Booth 423 to see how solution‑driven, end‑to‑end approaches can help immunotherapy teams reduce variability, improve reproducibility, and move confidently from complex models to biological insight.